Keyword: Department of Justice
Newly unsealed court documents allege Insys provided incentives for off-label prescribing of its painkiller Subsys.
The murky relationship between Valeant and now-defunct specialty pharmacy Philidor will spotlight a not-so-flattering chapter in its recent history.
Rita Luthra, M.D., was convicted Monday in a Warner marketing scheme—and in more evidence that it's the cover-up that gets you, for lying to investigators.
The Department of Justice has filed a motion to participate in opioid litigation settlement talks as a "friend of the court."
President Donald Trump Monday pledged to soon unveil a plan for drug prices and said the DOJ is considering suing opioid companies.
As opioid scrutiny intensifies around the country, Mallinckrodt has received another subpoena seeking info about its sales of the powerful painkillers.
Hundreds of cities and counties have sued to hold opioid makers accountable for the addiction epidemic. Now the feds are getting involved.
On Friday, a DOJ official signaled what his agency might do next in the yearslong generic drug price fixing probe.
More than a year after starting to probe pharma's ties with patient assistance charities, the feds have secured their first sizable settlement.
AmerisourceBergen has added $50 million more to resolve a DOJ probe into sales of cancer meds, taking its total in the matter to $885 million.